Clinical Trials Browser

Phase 1 × Lymphoma, T-Cell, Peripheral × belinostat × Clear all

NCT01839097 2020-01-03

Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

Phase 1 Completed

Lymphoma, T-Cell, Peripheral